Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Doxycycline in Acute Primary Anterior STEMI
NCT02562651Phase 3Unknown
- Sponsor
- Russian Academy of Sciences
- Start
- Feb 2014
- Primary completion
- Feb 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of doxycycline in ST elevation myocardial infarction (STEMI) (2 arms), sponsored by Russian Academy of Sciences. Primary endpoint: Changes in LV end-diastolic volumes index at 6 months. Status: unknown.
02
Drugs
doxycycline
03
Conditions
ST elevation myocardial infarction (STEMI)
Beyond the preview
Go deeper on NCT02562651.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02562651.